Arjun Kumar Manrai

Arjun Kumar Manrai

Auto-generated profile, based on publicly available information

Arjun Kumar Manrai

Department of Biomedical Informatics, Harvard Medical School, Boston, USA

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2009 in Cell
Verified
Journal Article
Closed access
QWQianben Wang
Qianben Wang
WLWei Li
Wei Li
YZYong Zhang
Yong Zhang
XYXin Yuan
Xin Yuan
KXKexin Xu
Kexin Xu
MBMyles Brown
Myles Brown

18 August 2016 in New England Journal of Medicine
Verified
Journal Article
Closed access
PDF file
AMArjun K. Manrai
Arjun K. Manrai
BFBirgit H. Funke
Birgit H. Funke
HHeidi Rehm
Heidi Rehm
MOMorten Olesen
Morten Olesen
BMBradley A. Maron
Bradley A. Maron
IKIsaac S. Kohane
Isaac S. Kohane
For more than a decade, risk stratification for hypertrophic cardiomyopathy has been enhanced by targeted genetic testing. Using sequencing results, clinicians routinely assess the risk of hypertrophic cardiomyopathy in a patient’s relatives and diagnose the condition in patients who have ambiguous clinical presentations. However, the benefits of genetic testing come with the risk that variants may be misclassified. Using publicly accessible exome data, we identified variants that have previously been considered causal in hypertrophic cardiomyopathy and that are overrepresented in the general population. We studied these variants in diverse populations and reevaluated their initial ascertainments in the medical literature. We reviewed patient records at a leading genetic-testing laboratory for occurrences of these variants during the near-decade-long history of the laboratory. Multiple patients, all of whom were of African or unspecified ancestry, received positive reports, with variants misclassified as pathogenic on the basis of the understanding at the time of testing. Subsequently, all reported variants were recategorized as benign. The mutations that were most common in the general population were significantly more common among black Americans than among white Americans (P<0.001). Simulations showed that the inclusion of even small numbers of black Americans in control cohorts probably would have prevented these misclassifications. We identified methodologic shortcomings that contributed to these errors in the medical literature. The misclassification of benign variants as pathogenic that we found in our study shows the need for sequencing the genomes of diverse populations, both in asymptomatic controls and the tested patient population. These results expand on current guidelines, which recommend the use of ancestry-matched controls to interpret variants. As additional populations of different ancestry backgrounds are sequenced, we expect variant reclassifications to increase, particularly for ancestry groups that have historically been less well studied. (Funded by the National Institutes of Health.)

18 August 2009 in Bioinformatics
Verified
Journal Article
Open access
PDF file
HSHyunjin Shin
Hyunjin Shin
TLTao Liu
Tao Liu
AMArjun K. Manrai
Arjun K. Manrai
XLX. Shirley Liu
X. Shirley Liu
Summary: We present a tool designed to characterize genome-wide protein–DNA interaction patterns from ChIP-chip and ChIP-Seq data. This stand-alone extension of our web application CEAS (cis-regulatory element annotation system) provides summary statistics on ChIP enrichment in important genomic regions such as individual chromosomes, promoters, gene bodies or exons, and infers the genes most likely to be regulated by the binding factor under study. CEAS also enables biologists to visualize the average ChIP enrichment signals over specific genomic regions, particularly allowing observation of continuous and broad ChIP enrichment that might be too subtle to detect from ChIP peaks alone. Availability: The CEAS Python package is publicly available at http://liulab.dfci.harvard.edu/CEAS. Contact:shin@jimmy.harvard.edu; xsliu@jimmy.harvard.edu Supplementary information: Supplementary data are available at Bioinformatics online.

1 March 2018 in Genetics in Medicine
Verified
Journal Article
Open access
MKMelissa A. Kelly
Melissa A. Kelly
CCColleen Caleshu
Colleen Caleshu
AMAna Morales
Ana Morales
JBJillian Buchan
Jillian Buchan
ZWZena Wolf
Zena Wolf
BFBirgit Funke
Birgit Funke
Integrating genomic sequencing in clinical care requires standardization of variant interpretation practices. The Clinical Genome Resource has established expert panels to adapt the American College of Medical Genetics and Genomics/Association for Molecular Pathology classification framework for specific genes and diseases. The Cardiomyopathy Expert Panel selected MYH7, a key contributor to inherited cardiomyopathies, as a pilot gene to develop a broadly applicable approach. Expert revisions were tested with 60 variants using a structured double review by pairs of clinical and diagnostic laboratory experts. Final consensus rules were established via iterative discussions. Adjustments represented disease-/gene-informed specifications (12) or strength adjustments of existing rules (5). Nine rules were deemed not applicable. Key specifications included quantitative frameworks for minor allele frequency thresholds, the use of segregation data, and a semiquantitative approach to counting multiple independent variant occurrences where fully controlled case-control studies are lacking. Initial inter-expert classification concordance was 93%. Internal data from participating diagnostic laboratories changed the classification of 20% of the variants (n = 12), highlighting the critical importance of data sharing. These adapted rules provide increased specificity for use in MYH7-associated disorders in combination with expert review and clinical judgment and serve as a stepping stone for genes and disorders with similar genetic and clinical characteristics.

30 March 2023 in New England Journal of Medicine
Verified
Journal Article
Closed access
ABAndrew L. Beam
Andrew L. Beam
JDJeffrey M. Drazen
Jeffrey M. Drazen
IKIsaac S. Kohane
Isaac S. Kohane
TLTze-Yun Leong
Tze-Yun Leong
AMArjun K. Manrai
Arjun K. Manrai
EREric J. Rubin
Eric J. Rubin

30 May 2024 in New England Journal of Medicine
Verified
Journal Article
Closed access
KYKun-Hsing Yu
Kun-Hsing Yu
EHElizabeth Healey
Elizabeth Healey
TLTze-Yun Leong
Tze-Yun Leong
IKIsaac S Kohane
Isaac S Kohane
AMArjun K Manrai
Arjun K Manrai